AXM Pharma, Inc. (AMEX: AXJ), a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that it has filed Form 12b-25 with the Securities and Exchange Commission granting the Company a 15-day extension to file its Form 10-K. for the period ended December 31, 2005. About AXM Pharma, Inc. AXM Pharma, Inc., through its wholly owned subsidiary, AXM Pharma Shenyang, Inc. ("AXM Shenyang"), is a manufacturer of proprietary and generic pharmaceutical products, which include injectables, capsules, tablets, liquids and medicated skin products for export and domestic Chinese sales. AXM Shenyang is located in the City of Shenyang, in the Province of Liaoning, China. AXM Shenyang has an operating history of approximately 10 years. For additional information on AXM Pharma Inc., please visit http://www.axmpharma.com.
Axm (AMEX:AXJ)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Axm 차트를 더 보려면 여기를 클릭.
Axm (AMEX:AXJ)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Axm 차트를 더 보려면 여기를 클릭.